Letendre Jo-Annie, Goggs Robert
Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY, 14853.
J Vet Emerg Crit Care (San Antonio). 2018 Nov;28(6):503-511. doi: 10.1111/vec.12773. Epub 2018 Oct 9.
To investigate the use of plasma cell-free DNA (cfDNA) and nucleosome concentrations as prognostic biomarkers in canine sepsis.
Prospective, observational cohort study conducted from June 2015 to February 2016.
University teaching hospital.
Forty-five dogs with sepsis, 10 dogs with nonseptic systemic inflammatory response syndrome (nSIRS), and 15 healthy controls were consecutively enrolled and followed to hospital discharge. Patients were eligible for enrollment if they met ≥2 SIRS criteria and had a documented or highly suspected bacterial infection. Dogs <3 kg or with a known coagulopathy were excluded.
None.
Acute Patient Physiology and Laboratory Evaluation scores (APPLE) were calculated and outcomes recorded. Plasma cfDNA was measured using a benchtop fluorimeter. Plasma nucleosome concentrations were determined by ELISA. Plasma nucleosome and cfDNA concentrations in dogs with sepsis or nSIRS were compared to those of healthy controls and cfDNA concentrations in septic dogs with and without bacteremia were compared. Associations between cfDNA concentrations and nucleosomes, leukocyte count, neutrophil count, and APPLE scores were evaluated. For septic dogs, cfDNA concentrations relative to neutrophil count and nucleosome concentrations in survivors and nonsurvivors were compared. Alpha was set at 0.05. cfDNA concentrations were significantly higher in dogs with sepsis or nSIRS compared to healthy controls (P < 0.0001 and P = 0.0034, respectively). Nucleosome concentrations were significantly higher in dogs with sepsis compared to healthy controls (P = 0.007). There was limited association between cfDNA and nucleosome concentrations (r = 0.266), and no association between cfDNA concentration and leukocyte count, neutrophil count, and APPLE scores. Concentrations of cfDNA were positively correlated with APPLE score (r = 0.335, P = 0.025); however, cfDNA concentrations were significantly higher in dogs with bacteremia (P = 0.0299). In dogs with sepsis, cfDNA concentrations relative to neutrophil count were significantly higher in nonsurvivors than in survivors (P = 0.008).
In dogs with sepsis, high cfDNA concentrations relative to neutrophil count are associated with nonsurvival. Point-of-care cfDNA measurement may aid identification of bacteremia.
研究血浆游离DNA(cfDNA)和核小体浓度作为犬脓毒症预后生物标志物的应用。
2015年6月至2016年2月进行的前瞻性观察队列研究。
大学教学医院。
45只患脓毒症的犬、10只患非脓毒症全身炎症反应综合征(nSIRS)的犬和15只健康对照犬连续入组并随访至出院。符合≥2条全身炎症反应综合征(SIRS)标准且有记录或高度怀疑细菌感染的患者符合入组条件。体重<3 kg或已知有凝血功能障碍的犬被排除。
无。
计算急性患者生理和实验室评估评分(APPLE)并记录结果。使用台式荧光计测量血浆cfDNA。通过酶联免疫吸附测定法测定血浆核小体浓度。比较脓毒症或nSIRS犬的血浆核小体和cfDNA浓度与健康对照犬的浓度,并比较有菌血症和无菌血症的脓毒症犬的cfDNA浓度。评估cfDNA浓度与核小体、白细胞计数、中性粒细胞计数和APPLE评分之间的相关性。对于脓毒症犬,比较存活犬和非存活犬相对于中性粒细胞计数的cfDNA浓度和核小体浓度。设定α为0.05。与健康对照犬相比,脓毒症或nSIRS犬的cfDNA浓度显著更高(分别为P < 0.0001和P = 0.0034)。与健康对照犬相比,脓毒症犬的核小体浓度显著更高(P = 0.007)。cfDNA与核小体浓度之间的关联有限(r = 0.266),cfDNA浓度与白细胞计数、中性粒细胞计数和APPLE评分之间无关联。cfDNA浓度与APPLE评分呈正相关(r = 0.335,P = 0.025);然而,有菌血症的犬的cfDNA浓度显著更高(P = 0.0299)。在脓毒症犬中,非存活犬相对于中性粒细胞计数的cfDNA浓度显著高于存活犬(P = 0.008)。
在脓毒症犬中,相对于中性粒细胞计数的高cfDNA浓度与非存活相关。即时检测cfDNA可能有助于菌血症的识别。